V2X, Inc. (NYSE:VVX) ("V2X"), a leading provider of global mission solutions, announced today the sale of 2.25 ...
Positive Phase 1 data for CTX310® presented in a late-breaking presentation at the American Heart Association (AHA) ...
Tech stocks and top consumer names are increasingly at risk of steep declines in a slowing economy. Click here to see 5 ...
CAMBRIDGE, Mass., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today ...
The company, formerly known as Doosan, is the third largest machine tool company and made its entry onto the industrial 3D ...
Data presented in a late-breaking presentation at the American Heart Association (AHA) Scientific Sessions 2025--Phase 1 ...
Nektar Therapeutics today presented new data from the ongoing REZOLVE-AD Phase 2b study in a late-breaking oral abstract presentation at the American College of Allergy, Asthma & Immunology (ACAAI) ...
Vertex Resource Group Ltd. ("Vertex" or the "Company") reports its financial and operational results for the third quarter ...
With immunology and inflammation blockbusters like AbbVie’s Skyrizi and Rinvoq reeling in nearly $7 billion combined in the ...
Good morning, everyone. My name is Dina Elmonshed, one of the U.S. biotech analysts here at UBS. And joining me today is the President and CEO of Vertex Pharmaceuticals, Reshma Kewalramani. Thank you ...
Raspberry Pi clusters have been a favorite project of homelabbers and distributed computing enthusiasts since the platform first launched over a decade ago, and for good reason. For an extremely low ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback